Materialise NV Cash and Short Term Investments

Cash and Short Term Investments of MTLS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cash and Short Term Investments growth rates and interactive chart. Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities. Cash and short term investments are considered very liquid assets.

Highlights and Quick Summary

  • Cash and Short Term Investments for the quarter ending September 29, 2021 was $230 Million (a 4.36% increase compared to previous quarter)
  • Year-over-year quarterly Cash and Short Term Investments increased by 80.43%
  • Annual Cash and Short Term Investments for 2020 was $127 Million (a -11.74% decrease from previous year)
  • Annual Cash and Short Term Investments for 2019 was $144 Million (a 5.83% increase from previous year)
  • Annual Cash and Short Term Investments for 2018 was $136 Million (a 179.53% increase from previous year)
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cash and Short Term Investments of Materialise NV

Most recent Cash and Short Term Investmentsof MTLS including historical data for past 10 years.

Interactive Chart of Cash and Short Term Investments of Materialise NV

Materialise NV Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 $229.88 $220.28 $129.68
2020 $127.41 $129.39 $138.14 $139.78 $127.41
2019 $144.36 $145.78 $122.36 $126.13 $144.36
2018 $136.41 $133.27 $58.1 $54.94 $136.41
2017 $48.8 $56.53 $59.21 $58.69 $48.8
2016 $61.87 $56.35 $57.95 $54.54 $61.87
2015 $56.29 $54.22 $58.29 $64.97 $56.29
2014 $81.11 $99.57 $106.21 $81.11

Business Profile of Materialise NV

Sector: Technology
Industry: Software—Application
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. It operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.